Avadel Pharmaceuticals PLC (NAS:AVDL)
$ 13.945 0.295 (2.16%) Market Cap: 1.34 Bil Enterprise Value: 1.24 Bil PE Ratio: 0 PB Ratio: 19.10 GF Score: 43/100

Q2 2021 Avadel Pharmaceuticals PLC Earnings Call Transcript

Aug 09, 2021 / 12:30PM GMT
Release Date Price: $7.79 (-1.39%)
Operator

Greetings. And welcome to the Avadel Pharmaceuticals second quarter 2021 earnings call.

(Operator Instructions)

As a reminder, this conference call is being recorded. It is now my pleasure to introduce Courtney Turiano. Thank you. You may began.

Courtney Turiano
Stern Investor Relations, Inc. - Client Lead

Good Morning and thank you for joining us on our conference call. This morning we issued our press release providing a corporate update and financial results for the quarter ended June 30, 2021. the release can be accessed on our website www.avadel.com.

As a reminder, before we began, the following presentation includes several matters that constitutes forward-looking statements within the meaning of the Private Security Litigation Reform Act of 1995. Forward-looking statements are subject to risks and uncertainties that can cause actual results to differ materially from those contemplated in such forward-looking statements. These risks include risks that product in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot